UCSF

ZINC34676244

Substance Information

In ZINC since Heavy atoms Benign functionality
September 21st, 2009 7 No

Other Names:

α (+)-4-Amino-3-isoxazolidinone; (+)-4-Amino-3-oxazolidinone; (+)-cycloserine; (+-)-4-Amino-3-isossazolidone [Italian]; (+-)-4-Amino-3-isoxazolidinone; (+-)-oxamicina [italian]; (-)-4-Amino-3-isossazolidone [Italian]; (1)-4-Amino-3-isoxazolidone; (4

α (+)-4-Amino-3-isoxazolidinone; (+)-4-Amino-3-oxazolidinone; (+)-cycloserine; (+-)-4-Amino-3-isossazolidone [Italian]; (+-)-4-Amino-3-isoxazolidinone; (+-)-oxamicina [italian]; (-)-4-Amino-3-isossazolidone [Italian]; (4R)-4-amino-1,2-oxazolidin-3-o

(+)-4-Amino-3-isoxazolidinone

(+)-Cycloserine

(-)-4-Amino-3-isossazolidone [Italian]; (S)-(-)-Cycloserine; (S)-4-Amino-3-isoxazolidinone; 3-Isoxazolidinone, 4-amino-, (L)-; 3-Isoxazolidinone, 4-amino-, (S)-; BRN 0080799; C3H6N2O2; Cyclo-L-serine; EINECS 206-427-0; L-4-Amino-3-isoxazolidinone; L-4-Ami

(-)-4-amino-3-isoxazolidinone; (-)-4-aminoisoxazolidin-3-one; (-)-cycloserine; (4S)-4-aminoisoxazolidin-3-one; (S)-(-)-cycloserine; (S)-4-amino-3-isoxazolidinone; (S)-4-amino-isoxazolidin-3-one; L-4-aminoisoxazolidin-3-one; L-CS; cyclo-L-serine

(4R)-4-amino-1,2-oxazolidin-3-one

(4R)-4-Amino-3-isoxazolidinone

(4R)-4-aminoisoxazolidin-3-one

(R)-(+)-4-Amino-3-isoxazolidinone

(R)-(+)-Cycloserine

(R)-3-Isoxazolidinone, 4-amino-

(R)-4-Amino-3-isoxazolidinone

(R)-4-Amino-3-isoxazolidone

(R)-4-AMINO-ISOXAZOLIDIN-3-ONE

(R)-4-Aminoisoxazolidin-3-one

(R)-Cycloserine

(S)-4-Aminoisoxazolidin-3-one

1pb9

3-Isoxazolidinone, 4-amino- (9CI)

3-Isoxazolidinone, 4-amino-, (+)-

3-Isoxazolidinone, 4-amino-, (+)- (8CI)

3-Isoxazolidinone, 4-amino-, (4R)- (9CI)

3-Isoxazolidinone, 4-amino-, (4S)- (9CI)

3-Isoxazolidinone, 4-amino-, (R)

3-Isoxazolidinone, 4-amino-, (R)-

3-Isoxazolidinone, 4-amino-, D

3-Isoxazolidinone, 4-amino-, d-

3-Isoxazolidinone,4-amino-

30020_FLUKA

30020_SIGMA

339-72-0; D04706; Levcycloserine (USAN/INN)

4-27-00-05549 (Beilstein Handbook Reference)

4-amino-1,2-oxazolidin-3-one

4-Aminoisoxazolidin-3-one

4AX

68-39-3; C06682; DL-Cycloserine

68-41-7

AB00443920

AC-4721

AC1L1M33

AC1Q4UA7

AI3-50153

alpha-Cycloserine

BB_NC-1631

BIDD:GT0707

BPBio1_001252

BRN 0080798

BSPBio_001138

BSPBio_002121

C 3909

C-9390

C-9400

C08057

C3909_SIGMA

C3H6N2O2

C6880_SIGMA

C7670_SIGMA

CAS-339-72-0

CAS-68-41-7

CHEBI:40009

CHEMBL771

Cicloserina

Cicloserina [INN-Spanish]

Cicloserina [Italian]

CID6234

Closerin

Closina

CPD-2482

CPD-2483; L-4-amino-3-isoxazolidinone; L-4-amino-3-isoxazolidone; L-cycloserine

CPD000058313

Cyclo-D-serine

Cyclorin

cycloserine

Cycloserine (JP15/USP/INN)

Cycloserine [INN:BAN:JAN]

Cycloserinum

Cycloserinum [INN-Latin]

D-(+)-Cycloserine

D-4-Amino-3-isossazolidone

D-4-Amino-3-isossazolidone [Italian]

D-4-amino-3-isoxazolidinone

D-4-amino-3-isoxazolidone

D-amino-3-isoxazolidinone

D-CS

D-Cycloserine, 98+%

D00877

DAP001468

DB03123

DivK1c_000098

DL-CYCLOSERINE

DRG-0195

E-733-A

EINECS 200-688-4

EU-0100252

FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09

Farmiserina

HMS1571I20

HMS1920C06

HMS2051C15

HMS2091I14

HMS500E20

HSDB 3218

I-1431

IDI1_000098

K-300

KBio1_000098

KBio2_001340

KBio2_003908

KBio2_006476

KBio3_001341

KBioGR_000890

KBioSS_001340

L-cycloserine

levcicloserina; levcycloserine; levcycloserinum

LEVCYCLOSERINE

Levcycloserine (INN

LMPK14000007

LS-86757

MFCD00005353

MFCD00064323

MFCD00064324

Micoserina

Miroserina

Miroseryn

MLS000758215

MLS001423962

MolPort-000-858-643

NCGC00015213-01

NCGC00015213-02

NCGC00015213-03

NCGC00016306-01

NCGC00016306-02

NCGC00016306-03

NCGC00016306-05

NCGC00093713-01

NCGC00093713-02

NINDS_000098

Novoserin

NSC 154851

orientomycin

Oxamicina

Oxamicina [Italian]

Oxamycin

PA 94

PA-94

Prestwick0_001089

Prestwick1_001089

Prestwick2_001089

Prestwick3_001089

R(+)-4-Amino-3-isoxazolidinone

R-(+)-Cycloserine

R-4-Amino-3-isoxazolidinone

RO-1-9213

S1998_Selleck

SAM001247014

SAM002264599

SC-49088

Serine, cyclo-

Seromycin

Seromycin (TN)

SMP1_000167

SMR000058313

SPBio_000008

SPBio_003029

SPECTRUM1500215

Spectrum2_000084

Spectrum3_000371

Spectrum4_000305

Spectrum5_000797

Spectrum_000860

Store at 0-5°C

Tebemicina

Tisomycin

UNII-95IK5KI84Z

USAN)

Wasserina

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) -1.71 -5.16 -42.02 3 4 0 72 102.093 0
Hi High (pH 8-9.5) -1.90 -3.9 -5.58 3 4 0 64 102.093 0
Hi High (pH 8-9.5) -1.71 -5.45 -39.35 2 4 -1 71 101.085 0
Lo Low (pH 4.5-6) -1.71 -5.95 -46.71 4 4 1 69 103.101 0

Vendor Notes

Note Type Comments Provided By
Melting_Point 137? dec. Alfa-Aesar
Melting_Point 137° dec. Alfa-Aesar
MP 138-141° Oakwood Chemical
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Purity 95% Fluorochem
Notes Cycloserine interferes with the bacterial cell wall synthesis by competing with D-Alanine for incorporation into the cell wall. Apollo Scientific Bioactives
Therapy enzyme inhibitor, Gaucher's disease therapy SMDC Pharmakon
PUBCHEM_PATENT_ID EP0948616A2; US5925354; WO1998018917A2 IBM Patent Data

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )